GeneDx announces that the FDA has granted Breakthrough Device Designation for its whole genome and exome tests.

New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic researchWALTHAM, Mass.--(BUSINESS WIRE)- ...

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it ...

Skin and hair problems have become increasingly common today, often triggered by stress, lifestyle changes, and environmental factors. But as concerns grow, so does the technology to address them. Dr ...

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on ...

CINCINNATI—Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver ...

The annual meeting of the American Academy of Ophthalmology was held from Oct. 18 to 20 in Orlando, Florida, and attracted ...

Kolkata: Suraksha Diagnostic Limited (Suraksha Clinic and Diagnostics), one of Eastern India’s leading diagnostic chains, organized an insightful scientific session on “Advances in Genetics ...

A growing number of people are getting genetic testing for breast cancer, which has become more comprehensive and ...

Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...

Human embryos formed with in vitro fertilisation can develop genetic abnormalities in the time between genetic testing and ...